Elixxer Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ELIXF research report →
About the company
Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, production, and sale of medicinal and specialized cannabis, as well as cannabis-derived products, predominantly for the pharmaceutical sector.
- CEO
- Karim Mecklai
- IPO
- 2017
- HQ
- Montreal, QC, CA
Price Chart
- Market Cap
- $23.35M
- P/E
- -0.14
- P/S
- 0.00
- P/B
- -0.05
- EV/EBITDA
- -64.62
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 29.22%
- ROIC
- 380.09%
- Revenue
- $0 · 0.00%
- Net Income
- $-3,865,565 · -111460.32%
- EPS
- $-0.34 · -84900.00%
- Op Income
- $-665,378
- FCF YoY
- 0.00%
- 52W High
- $0.10
- 52W Low
- $0.00
- 50D MA
- $0.03
- 200D MA
- $0.04
- Beta
- -0.54
- Avg Volume
- 538.072
Get TickerSpark's AI analysis on ELIXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ELIXF coverage
Recent articles, reports, and earnings notes.
No research on ELIXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ELIXF report →Similar companies
Peers in the same neighborhood.